[en] BACKGROUND: Many patients with bi-lobar liver tumours are not eligible for liver resection due to an insufficient future liver remnant (FLR). To reduce the risk of posthepatectomy liver failure and the primary cause of death, regenerative procedures intent to increase the FLR before surgery. The aim of this systematic review is to provide an overview of the available literature and outcomes on the effectiveness of simultaneous portal and hepatic vein embolization (PVE/HVE) versus portal vein embolization (PVE) alone. METHODS: A systematic literature search was conducted in PubMed, Web of Science, and Embase up to September 2022. The primary outcome was resectability and the secondary outcome was the FLR volume increase. RESULTS: Eight studies comparing PVE/HVE with PVE and six retrospective PVE/HVE case series were included. Pooled resectability within the comparative studies was 75 per cent in the PVE group (n = 252) versus 87 per cent in the PVE/HVE group (n = 166, OR 1.92 (95% c.i., 1.13-3.25)) favouring PVE/HVE (P = 0.015). After PVE, FLR hypertrophy between 12 per cent and 48 per cent (after a median of 21-30 days) was observed, whereas growth between 36 per cent and 67 per cent was reported after PVE/HVE (after a median of 17-31 days). In the comparative studies, 90-day primary cause of death was similar between groups (2.5 per cent after PVE versus 2.2 per cent after PVE/HVE), but a higher 90-day primary cause of death was reported in single-arm PVE/HVE cohort studies (6.9 per cent, 12 of 175 patients). CONCLUSION: Based on moderate/weak evidence, PVE/HVE seems to increase resectability of bi-lobar liver tumours with a comparable safety profile. Additionally, PVE/HVE resulted in faster and more pronounced hypertrophy compared with PVE alone.
Disciplines :
Surgery Gastroenterology & hepatology Radiology, nuclear medicine & imaging
Author, co-author :
Korenblik, Remon ; Department of Surgery, Maastricht University Medical Center, Maastricht, The ; GROW-Department of Surgery, School for Oncology and Reproduction, Maastricht
van Zon, Jasper F J A; Department of Surgery, Maastricht University Medical Center, Maastricht, The
Olij, Bram; Department of Surgery, Maastricht University Medical Center, Maastricht, The ; GROW-Department of Surgery, School for Oncology and Reproduction, Maastricht ; Department of General, Visceral and Transplant Surgery, University Hospital RWTH
Heil, Jan; Department of General, Visceral and Transplant Surgery, University Hospital
Dewulf, Maxime J L; Department of Surgery, Maastricht University Medical Center, Maastricht, The
Neumann, Ulf P; Department of Surgery, Maastricht University Medical Center, Maastricht, The ; Department of General, Visceral and Transplant Surgery, University Hospital RWTH
Olde Damink, Steven W M; Department of Surgery, Maastricht University Medical Center, Maastricht, The ; Department of General, Visceral and Transplant Surgery, University Hospital RWTH ; NUTRIM-Department of Surgery, School of Nutrition and Translational Research in
Binkert, Christoph A; Department of Radiology, Cantonal Hospital Winterthur, Winterthur, Switzerland.
Schadde, Erik ; Department of General, Visceral and Transplant Surgery, Klinik Hirslanden, ; Department of General, Visceral and Transplant Surgery, Hirslanden Klink St. Anna
van der Leij, Christiaan; Department of Radiology, Maastricht University Medical Center+, Maastricht, The
van Dam, Ronald M; Department of Surgery, Maastricht University Medical Center, Maastricht, The ; GROW-Department of Surgery, School for Oncology and Reproduction, Maastricht ; Department of General, Visceral and Transplant Surgery, University Hospital RWTH
DRAGON Trials, Collaborative
Other collaborator :
Aldrighetti, L A
van Baardewijk, L J
Barbier, L
Binkert, C A
Billingsley, K
Björnsson, B
Andorrà, E Cugat
Arslan, B
Baclija, I
Bemelmans, M H A
Bent, C
de Boer, M T
Bokkers, R P H
de Boo, D W
Breen, D
Breitenstein, S
Bruners, P
Cappelli, A
Carling, U
Robert, M Casellas I
Chan, B
De Cobelli, F
Choi, J
Crawford, M
Croagh, D
van Dam, R M
Deprez, F
Detry, Olivier ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chirurgie abdo, sénologique, endocrine et de transplantation
Dewulf, M J L
Díaz-Nieto, R
Dili, A
Erdmann, J I
Font, J Codina
Davis, R
Delle, M
Fernando, R
Fisher, O
Fouraschen, S M G
Fretland, Å A
Fundora, Y
Gelabert, A
GERARD, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiodiagnostic
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917
Jemal A, Bray F, Ferlay J. Global cancer statistics: 2011. CA Cancer J Clin 1999;49:33-64
Van Cutsem E, Cervantes A, Nordlinger B, Arnold D, The ESMO Guidelines Working Group. Metastatic colorectal cancer: eSMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2014;25(Suppl 3): iii1-iii9
Cescon M, Vetrone G, Grazi GL, Ramacciato G, Ercolani G, Ravaioli M et al. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 2009;249:995-1002
Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002;236:397-406
Nanashima A, Tobinaga S, Abo T, Nonaka T, Takeshita H, Hidaka S et al. Reducing the incidence of post-hepatectomy hepatic complications by preoperatively applying parameters predictive of liver function. J Hepatobiliary Pancreat Sci 2010;17:871-878
Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Cho CK et al. Comparison of remnant to total functional liver volume ratio and remnant to standard liver volume ratio as a predictor of postoperative liver function after liver resection. Korean J Hepato-Biliary-Pancreatic Surg 2013;17:143-151
Schindl MJ, Redhead DN, Fearon KCH, Garden OJ, Wigmore SJ. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54:289-296
Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003;7:325-330
Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999;188:304-309
Kishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg 2009;250:540-548
Ferrero A, Viganò L, Polastri R, Muratore A, Eminefendic H, Regge D et al. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg 2007;31:1643-1651
Suda K, Ohtsuka M, Ambiru S, Kimura F, Shimizu H, Yoshidome H et al. Risk factors of liver dysfunction after extended hepatic resection in biliary tract malignancies. Am J Surg 2009;197: 752-758
Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986;10:803-808
Rous P, Larimore LD. Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J Exp Med 1920;31:609-632
Van Lienden KP, Van Den Esschert JW, De Graaf W, Bipat S, Lameris JS, Van Gulik TM et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol 2013;36:25-34
Kawaguchi Y, Lillemoe HA, Vauthey JN. Dealing with an insufficient future liver remnant: pVE and two-stage hepatectomy. J Surg Oncol 2019;119:594
Guiu B, Pierredon M, Schembri V, Ramos J, Chevallier P, Denys A. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. J Vasc Interv Radiol 2016;27:e60
Le Roy B, Perrey A, Fontarensky M, Gagnière J, Abergel A, Pereira B et al. Combined preoperative portal and hepatic vein embolization (biembolization) to improve liver regeneration before Major liver resection: a preliminary report. World J Surg 2017;41:1848-1856
Laurent C, Fernandez B, Marichez A, Adam JP, Papadopoulos P, Lapuyade B et al. Radiological Simultaneous Portohepatic Vein Embolization (RASPE) before Major hepatectomy: a better way to optimize liver hypertrophy compared to portal vein embolization. Ann Surg 2020;272:199-205
Heil J, Korenblik R, Heid F, Bechstein WO, Bemelmans M, Binkert C et al. Preoperative portal vein or portal and hepatic vein embolization: dRAGON collaborative group analysis. Br J Surg 2021;108:834-842
Esposito F, Lim C, Lahat E, Shwaartz C, Eshkenazy R, Salloum C et al. Combined hepatic and portal vein embolization as preparation for major hepatectomy: a systematic review. HPB (Oxford) 2019;21:1099-1106
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ2021;372:n71
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016;5:210
Thomas BH, Ciliska D, Dobbins M, Micucci S. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews evidence-based Nurs 2004;1:176-184
Hwang S, Ha T-Y, Ko G-Y, Kwon D-I, Song G-W, Jung D-H et al. Preoperative sequential portal and hepatic vein embolization in patients with hepatobiliary malignancy. World J Surg 2015; 39:2990-2998
Niekamp AS, Huang SY, Mahvash A, Odisio BC, Ahrar K, Tzeng CWD et al. Hepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma. Eur Radiol 2020; 30:3862-3868
Panaro F, Giannone F, Riviere B, Sgarbura O, Cusumano C, Deshayes E et al. Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center. Hepatobiliary Surg Nutr 2019;8:329-337
Guiu B, Quenet F, Panaro F, Piron L, Cassinotto C, Herrerro A et al. Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changes. Hepatobiliary Surg Nutr 2020;9:56476-56576
Hocquelet A, Sotiriadis C, Duran R, Denys A, Guiu B, Yamaguchi T et al. Preoperative portal vein embolization alone with biliary drainage compared to a combination of simultaneous portal vein, right hepatic vein embolization and biliary drainage in klatskin tumor. Cardiovasc Intervent Radiol 2018;41:1885-1891
Le Roy B, Gallon A, Cauchy F, Pereira B, Gagnière J, Lambert C et al. Combined biembolization induces higher hypertrophy than portal vein embolization before major liver resection. HPB (Oxford) 2020;22:298-305
Kobayashi K, Yamaguchi T, Denys A, Perron L, Halkic N, Demartines N et al. Liver venous deprivation compared to portal vein embolization to induce hypertrophy of the future liver remnant before major hepatectomy: a single center experience. Surgery 2020;167:917-923
Guiu B, Quenet F, Escal L, Bibeau F, Piron L, Rouanet P et al. Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function. Eur Radiol 2017;27:3343-3352
Le Roy B, Gagniere J, Perrey A, Fontarensky M, Boyer L, Pezet D et al. Combined preoperative portal and hepatic vein embolization (biembolization) to improve liver regeneration before Major liver resection: a preliminary Report. World J Surg 2017;41:1848-1856
Chebaro A, Buc E, Durin T, Chiche L, Brustia R, Didier A et al. Liver venous deprivation or associating liver partition and portal vein ligation for staged hepatectomy?: a retrospective multicentric study. Ann Surg 2021;274:874-880
Ghosn M, Kingham TP, Ridouani F, Santos E, Yarmohammadi H, Boas FE et al. Percutaneous liver venous deprivation: outcomes in heavily pretreated metastatic colorectal cancer patients. HPB (Oxford) 2022;24:404-412
Cassese G, Troisi RI, Khayat S, Quenet F, Tomassini F, Panaro F et al. Liver venous deprivation versus associating liver partition and portal vein ligation for staged hepatectomy for colorectal liver metastases: a comparison of early and late kinetic growth rates, and perioperative and oncological outcomes. Surg Oncol 2022;43:101812
Hocquelet A, Sotiriadis C, Duran R, Guiu B, Yamaguchi T, Halkic N et al. Preoperative portal vein embolization alone with biliary drainage compared to a combination of simultaneous portal vein, right hepatic vein embolization and biliary drainage in Klatskin tumor. Cardiovasc Intervent Radiol 2018;41:1885-1891
Böning G, Fehrenbach U, Auer TA, Neumann K, Jonczyk M, Pratschke J et al. Liver venous deprivation (LVD) versus portal vein embolization (PVE) alone prior to extended hepatectomy: a matched pair analysis. Cardiovasc Interv Radiol 2022;45:950-957
Ghosn M, Kingham TP, Ridouani F, Santos E, Yarmohammadi H, Boas FE et al. Percutaneous liver venous deprivation: outcomes in heavily pretreated metastatic colorectal cancer patients. HPB (Oxford) 2021;24:404-412
Heil J, Schadde E. Simultaneous portal and hepatic vein embolization before major liver resection. Langenbecks Arch Surg 2021;406:1295-1305
Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 2013;216:201-209
Deshayes E, Piron L, Bouvier A, Lapuyade B, Lermite E, Vervueren L et al. Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colorectal liver metastases. BMC Cancer 2020;20:1-7
Korenblik R, Olij B, Aldrighetti LA, Hilal MA, Ahle M, Arslan B et al. Dragon 1 protocol manuscript: training, accreditation, implementation and safety evaluation of portal and hepatic vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy. Cardiovasc Intervent Radiol 2022;45:1391-1398
